logo

Morphosys Ag (MOR)



Trade MOR now with
  Date
  Headline
11/4/2020 5:24:22 PM MorphoSys Plans To Present Data On Tafasitamab At ASH Annual Meeting
10/27/2020 9:21:23 PM MorphoSys Raises 2020 Outlook
10/19/2020 1:06:09 AM Janssen Receives CHMP Positive Opinion For Tremfya For Treatment Of Adults With PsA In EU
10/13/2020 11:03:15 AM MorphoSys Says Successfully Places EUR 325 Mln Convertible Bonds
10/13/2020 1:50:09 AM MorphoSys AG Launches Offering Of Approx. EUR 325 Mln Convertible Bonds
8/5/2020 4:32:39 PM MorphoSys AG Q2 Group Revenues EUR 18.4 Mln Vs EUR 34.7 Mln Last Year
7/14/2020 4:12:14 PM MorphoSys: Janssen Gets FDA Approval Of Tremfya To Treat Adults With Active Psoriatic Arthritis
5/14/2020 9:34:56 AM MorphoSys, Incyte Report Updated Results From Ongoing Phase 2 L-MIND Study
5/6/2020 4:43:21 PM MorphoSys Q1 Basic EPS EUR 6.12 Vs Loss EUR 0.72 Last Year
4/27/2020 5:30:16 PM MorphoSys And I-Mab: First Patient Dosed In Phase 3 Clinical Trial of MOR202/TJ202 In R/r Multiple Myeloma In China
4/21/2020 4:21:22 PM MorphoSys Appoints Roland Wandeler Chief Commercial Officer